CLINICAL_TRIALS
trial_result
· 2011-06-28
Clinical Trial Update: Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus [Phase 1]
Summary
This document provides an update on a Phase 1 study of BHT-3021 in subjects with Type 1 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayhill Therapeutics | Conditions: Diabetes, Hypoglycemia | Phase 1 | Status: COMPLETED